Cargando…
Pilot Study of Anti-Th2 Immunotherapy for the Treatment of Breast Cancer-Related Upper Extremity Lymphedema
SIMPLE SUMMARY: Lymphedema is a common complication of cancer, and patients with lymphedema have substantially decreased quality of life and suffer from lifelong symptoms. This study aimed to examine the effect of inhibition of Th2 inflammation in lymphedema by using QBX258, a combination of IL4/13...
Autores principales: | Mehrara, Babak J., Park, Hyeung Ju, Kataru, Raghu P., Bromberg, Jacqueline, Coriddi, Michelle, Baik, Jung Eun, Shin, Jinyeon, Li, Claire, Cavalli, Michele R., Encarnacion, Elizabeth M., Lee, Meghan, Van Zee, Kimberly J., Riedel, Elyn, Dayan, Joseph H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8466465/ https://www.ncbi.nlm.nih.gov/pubmed/34571811 http://dx.doi.org/10.3390/biology10090934 |
Ejemplares similares
-
Skin microbiome alterations in upper extremity secondary lymphedema
por: Campbell, Adana-Christine, et al.
Publicado: (2023) -
TGF‐β1 mediates pathologic changes of secondary lymphedema by promoting fibrosis and inflammation
por: Baik, Jung Eun, et al.
Publicado: (2022) -
Pharmacological Treatment of Secondary Lymphedema
por: Brown, Stav, et al.
Publicado: (2022) -
Preoperative Assessment of Upper Extremity Secondary Lymphedema
por: Wiser, Itay, et al.
Publicado: (2020) -
Assessing Secondary Upper Extremity Lymphedema Patients for Surgical Intervention
por: Wiser, Itay, et al.
Publicado: (2020)